ChromaDex to Present at the Lytham Partners 2024 Investor Select Conference

Rhea-AI Summary

ChromaDex Corp. (NASDAQ:CDXC) CEO and CFO will be participating in the Lytham Partners 2024 Investor Select Conference for virtual one-on-one meetings. The event is scheduled for Thursday, February 1, 2024. For more information, visit www.chromadex.com and www.investors.chromadex.com.

LOS ANGELES--(BUSINESS WIRE)-- ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD⁺) and healthy aging research, today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Brianna Gerber, will be participating in the Lytham Partners 2024 Investor Select Conference.

Mr. Fried and Mrs. Gerber will participate in virtual one-on-one meetings throughout the event on Thursday, February 1, 2024.

To arrange a meeting with the ChromaDex management team, please contact Lytham Partners at 1x1@lythampartners.com or register for the event at https://lythampartners.com/select2024invreg/.

For additional information on ChromaDex, visit www.chromadex.com, and for details on investor relations, please visit www.investors.chromadex.com.

About ChromaDex:

ChromaDex Corp. is a global bioscience company dedicated to healthy aging. The ChromaDex team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. ChromaDex is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex’s patent portfolio. ChromaDex maintains a website at www.chromadex.com to which ChromaDex regularly posts copies of its press releases as well as additional and financial information about the Company.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240126139680/en/

ChromaDex Media Contact:

Kendall Knysch, Head of Public Relations & Partnerships

310-388-6706 ext. 689

kendall.knysch@chromadex.com

ChromaDex Investor Relations Contact:

+1 (949) 356-1620

InvestorRelations@ChromaDex.com

Source: ChromaDex Corporation

FAQ

What is the purpose of ChromaDex's participation in the Lytham Partners 2024 Investor Select Conference?

ChromaDex's CEO and CFO will be participating in virtual one-on-one meetings at the conference to engage with potential investors.

When is the Lytham Partners 2024 Investor Select Conference taking place?

The event is scheduled for Thursday, February 1, 2024.

How can one arrange a meeting with the ChromaDex management team at the conference?

To arrange a meeting, contact Lytham Partners at 1x1@lythampartners.com or register for the event at https://lythampartners.com/select2024invreg/.

Where can I find more information about ChromaDex?

For additional information on ChromaDex, visit www.chromadex.com.

Where can I find details on ChromaDex's investor relations?

For details on investor relations, please visit www.investors.chromadex.com.